Edward T. Mathers

Filings by Edward T. Mathers span 9 companies, the busiest being Rhythm Pharmaceuticals, Inc., OnKure Therapeutics, Inc. and Korro Bio, Inc. In total, 17 filings cover trades dated from 28 June 2021 to 12 March 2026.

Purchases make up the whole of the open-market record (3 purchases, €3.8M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 6 share grants and 2 option exercises. In 2026 alone, the filings show 1 purchase and no sales.

The median purchase comes to €939k. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 16 March 2026, reports a transaction in Rhythm Pharmaceuticals, Inc. The last purchase on record was published on 12 March 2026, which is 220 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.